05.01.15
Galderma: named a new president of Galderma Laboratories, L.P. along with a new leadership team in anticipation of several new product launches in the upcoming months.
The new leadership team includes Todd Zavodnick, former vice president and general manager for the Aesthetic and Corrective business, has been appointed president and general manager of Galderma Laboratories, L.P. During the past 10 years, he held leadership roles in Asia, Europe, Middle East, Africa, and Latin America for Alcon Laboratories and Galderma Laboratories. In the interim, Zavodnick will continue leading the Aesthetic and Corrective Business Unit. A new vice president will be appointed in the upcoming months.
Safia Rizvi is vice president and general manager of US Prescription Business Unit. She was formally the managing director and general manager of UCB Pharmaceuticals in Mumbai, India.
Miles Harrison has been named vice president and general manager US Self-Medication Business. He joined Galderma from Novartis.
Dr. Philip Brown continues to serve as senior vice president of medical and regulatory affairs.
The new leadership team includes Todd Zavodnick, former vice president and general manager for the Aesthetic and Corrective business, has been appointed president and general manager of Galderma Laboratories, L.P. During the past 10 years, he held leadership roles in Asia, Europe, Middle East, Africa, and Latin America for Alcon Laboratories and Galderma Laboratories. In the interim, Zavodnick will continue leading the Aesthetic and Corrective Business Unit. A new vice president will be appointed in the upcoming months.
Safia Rizvi is vice president and general manager of US Prescription Business Unit. She was formally the managing director and general manager of UCB Pharmaceuticals in Mumbai, India.
Miles Harrison has been named vice president and general manager US Self-Medication Business. He joined Galderma from Novartis.
Dr. Philip Brown continues to serve as senior vice president of medical and regulatory affairs.